Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000426373 | SCV000525406 | likely benign | not specified | 2016-11-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV004563340 | SCV000647530 | likely benign | Familial adenomatous polyposis 1 | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000572790 | SCV000676344 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000426373 | SCV001362490 | likely benign | not specified | 2019-12-21 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000572790 | SCV004361330 | likely benign | Hereditary cancer-predisposing syndrome | 2022-11-06 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004000416 | SCV004820402 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-11-20 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004563340 | SCV004931943 | benign | Familial adenomatous polyposis 1 | 2024-03-27 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |